Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sarah Serl"'
Autor:
Brad Thompson, Amine Kamen, Romit Chakrabarty, Sarah Serl, Zhenbao Yu, Allison Hagerman, Matthew C. Coffey, Hue Tran, Yves Fortin, David Onions, Shi-Hsiang Shen, Robert Voyer, J L Kolman
Publikováno v:
Applied microbiology and biotechnology. 98(4)
REOLYSIN® (pelareorep) is a proprietary isolate of the reovirus T3D (Type 3 Dearing) strain which is currently being tested in clinical trials as an anticancer therapeutic agent. Reovirus genomes are composed of ten segments of double-stranded ribon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7253d7d433d736616e7a416591201678
https://pubmed.ncbi.nlm.nih.gov/24419798
https://pubmed.ncbi.nlm.nih.gov/24419798
Autor:
Hue Tran, Tanya Moran, Iohann Boulay, Brad Thompson, Allison Hagerman, Romit Chakrabarty, Robert Tavcar, Audrey Parenteau, Matthew C. Coffey, Sarah Serl, Maude Bigras
Publikováno v:
Investigational new drugs. 31(6)
Numerous pre-clinical and clinical studies on reovirus have generated valuable information which supports the use of this orphan virus as an investigational drug for cancer treatment. Reolysin® (pelareorep) is a clinical formulation of the human Reo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a414d91417b40a0c2c6338e4604d2654
https://pubmed.ncbi.nlm.nih.gov/24121993
https://pubmed.ncbi.nlm.nih.gov/24121993